Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.9%

1 terminated/withdrawn out of 106 trials

Success Rate

98.1%

+11.6% vs industry average

Late-Stage Pipeline

10%

11 trials in Phase 3/4

Results Transparency

12%

6 of 51 completed trials have results

Key Signals

16 recruiting6 with results

Enrollment Performance

Analytics

N/A

38(62.3%)

Phase 2

11(18.0%)

Phase 3

8(13.1%)

Phase 4

3(4.9%)

Early Phase 1

1(1.6%)

61Total

N/A(38)

Phase 2(11)

Phase 3(8)

Phase 4(3)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (106)

Showing 20 of 106 trials

NCT05366569Recruiting

Bio-CAR-T BS Study

Role: lead

NCT03058588Recruiting

Next Generation Sequencing (NGS) in Familial Acute Myeloid Leukemia and Myelodisplastic Syndromes

Role: lead

NCT07420790Recruiting

Design and Validation of a Generative AI and Propensity Score Matching Model for the VEN-DEC Phase II Study in Elderly AML Eligible for Allo-SCT; Evaluation of an Exploratory Approach Respect to a Randomized Phase III Trial

Role: lead

NCT07482280Not ApplicableCompleted

Clinical Efficacy of Vector Paro With Hydroxyapatite in the Supportive Therapy of Periodontitis

Role: lead

NCT06493708Not ApplicableRecruiting

Effectiveness of EMDR in Borderline Personality Disorder

Role: lead

NCT07370961Not ApplicableCompleted

Pilot Study to Evaluate the Impact of a Multidisciplinary Approach (Pharmacological and Psychological) in the Treatment of Chronic Kidney Disease-Associated Pruritus

Role: lead

NCT07232953Phase 2Active Not Recruiting

Safety and Efficacy of FT14 Conditioning for Allogeneic HSCT in Acute Myeloid Leukemia

Role: lead

NCT07085572Phase 2Recruiting

Cemiplimab as Maintenance Treatment for Advanced Adrenocortical Cancer

Role: lead

NCT05847387Recruiting

The Viability Control of Human Endothelial Cells Before Keratoplasty (V-CHECK) Study

Role: lead

NCT05756621Recruiting

Dual Anti-glutamate Therapy in Super-refractory Status Epilepticus After Cardiac Arrest

Role: collaborator

NCT04478643Not ApplicableCompleted

Lactobacillus Reuteri in the Supportive Therapy of Periodontitis

Role: lead

NCT07010068Not ApplicableNot Yet Recruiting

Nutritional Support With TGF-β2 Food for Special Medical Purposes (TGF-β2 FSMP) in Adult Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) for the Prevention of Malnutrition: a Prospective, Randomized, Multicenter Study

Role: lead

NCT05643326Not ApplicableCompleted

At Home Gamma tACS in Alzheimer's Disease (tACS@Home)

Role: lead

NCT06805812Recruiting

Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study

Role: collaborator

NCT06765343Not ApplicableCompleted

Efficacy of Guided Biofilm Therapy in Pediatric Patient

Role: lead

NCT06627998Recruiting

Study of the Prevalence of Osteo-metabolic Complications in Patients With Thyroid Cancer

Role: collaborator

NCT04432974Not ApplicableCompleted

Automatic Control of Total Intravenous Anesthesia (ACTIVA)

Role: lead

NCT06071195Recruiting

All-in-One Prostate Cancer Staging with MRI